Process for producing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide

The novel process for producing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide enhances yield and chiral purity through a series of targeted reactions, addressing inefficiencies in existing methods.

JP7579322B2Active Publication Date: 2024-11-07MERCK PATENT GMBH
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2022500028
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-07-03
Filing Date
2020-06-30
Publication Date
2024-11-07
Estimated Expiration
2040-06-30

AI Technical Summary

Technical Problem

The existing methods for producing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide are inefficient, requiring multiple steps and low overall yields, particularly in the racemic synthesis followed by chiral separation.

Method used

A novel process involving the reaction of 2-oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidine-3-carboxylic acid with 3,5-difluorobenzylamine, followed by enantioselective oxidation and subsequent cleavage of the phenylsulfonyl group, using specific reagents and conditions to enhance yield and purity.

Benefits of technology

The process achieves a higher overall yield of 27% in three additional steps compared to the existing methods, with improved efficiency and chiral purity, specifically achieving an enantiomeric excess of 98.7%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007579322000001
    Figure 0007579322000001
  • Figure 0007579322000002
    Figure 0007579322000002
  • Figure 0007579322000003
    Figure 0007579322000003
Patent Text Reader

Abstract

A process for producing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention aims at finding new compounds which have valuable properties, in particular properties which can be used for the preparation of medicines.

[0002] The present invention relates to a process for producing the MetAP-2 inhibitor (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide ("S-9"), which was synthesized in a key step with an asymmetric oxidizing agent: "Davis oxaziridine". [Background technology]

[0003] Davis oxaziridine: (+)-(2R,4aS,7S,8aR)-4H-4a, 7-methanooxazirino[3,2-i][2,1]benzisothiazole, 8,8-dichlorotetrahydro-9,9-dimethyl-3,3-dioxide

[0004] [ka]

[0005] This process for the preparation of "S-9" is not known.

[0006] Prior art documents WO2012048775, WO2013149704 and WO2016020031 disclose racemic synthesis followed by chiral separation for the preparation of racemic compounds.

[0007] Analysis / comparison of both methods, racemic synthesis versus the claimed asymmetric route, clearly demonstrates that the asymmetric oxidation is superior to the state of the art: the asymmetric process requires fewer steps and is more productive.

[0008] Scheme 1 gives an overview of how the routes differ. The common intermediate is compound number 5. Starting from this compound 5, the ready-made route requires five additional synthetic steps and chiral chromatography to obtain the desired enantiomer S-9 in 15% overall yield.

[0009] The yield could be increased via three additional steps (R-9 to 10: alcohol activation; 10 to 11: inversion; 11 to S-9: hydrolysis), but the workload was significantly increased. This new process affords S-9 from 5 in three additional steps in an overall yield of 27%. The key step is the enantioselective oxidation of 1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-2-oxopyrrolidine-3-carboxamide (12) to give (3S)-1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-3-hydroxy-2-oxopyrrolidine-3-carboxamide (13).

[0010] Scheme 1: [ka]

[0011] prior art Prior art documents WO2012 / 048775, WO2013 / 149704 and WO2016020031 disclose racemic synthesis followed by chiral separation for the preparation of racemic compounds. (S)-3-Hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide was disclosed as "B8" in WO2013 / 149704. Summary of the Invention

[0012] SUMMARY OF THE PRESENT APPLICATION The present invention relates to a process for producing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide ("S-9"), comprising: a) 2-oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidine-3-carboxylic acid ("5") is reacted with 3,5-difluorobenzylamine to provide 1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-2-oxopyrrolidine-3-carboxamide ("12");

[0013] b) "12" is then enantioselectively oxidized to afford (3S)-1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-3-hydroxy-2-oxopyrrolidine-3-carboxamide ("13"); c) and then cleaving the phenylsulfonyl group from "13" to give (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide ("S-9"); The present invention relates to the process,

[0014] Preferably, the present invention relates to a process for producing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide ("S-9"), comprising: 2-oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidine-3-carboxylic acid ("5") is reacted with 3,5-difluorobenzylamine to provide 1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-2-oxopyrrolidine-3-carboxamide ("12");

[0015] "12" is then reacted with (+)-(2R,4aS,7S,8aR)-4H-4a, 7-methanooxazirino[3,2-i][2,1]benzisothiazole, 8,8-dichlorotetrahydro-9,9-dimethyl-3,3-dioxide to provide (3S)-1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-3-hydroxy-2-oxopyrrolidine-3-carboxamide ("13"); and subsequently cleaving the phenylsulfonyl group from "13" to provide (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide ("S-9"). The present invention relates to the process,

[0016] The reaction of compound 5 with 3,5-difluorobenzylamine in step 4C is generally carried out in the presence of an organic base such as DIPEA, triethylamine, dimethylaniline, pyridine, quinoline, diazabicycloundecene, (DBU) or di-isopropylethylamine (Huenig's base). Most preferably, the reaction is carried out in the presence of triethylamine, DBU or di-isopropylethylamine.

[0017] Depending on the conditions used, the reaction time is between a few minutes and 14 days, the reaction temperature is between about -30° and 140°, usually between -10° and 90°, in particular between about 0° and about 40°.

[0018] The reaction is preferably carried out in an inert solvent. Examples of suitable inert solvents are hydrocarbons such as hexane, petroleum ether, benzene, toluene or xylene; chlorinated hydrocarbons such as trichloroethylene, 1,2-dichloroethane, carbon tetrachloride, chloroform or dichloromethane; alcohols such as methanol, ethanol, isopropanol, n-propanol, n-butanol or tert-butanol; ethers such as diethyl ether, diisopropyl ether, tetrahydrofuran (THF) or dioxane; glycol ethers such as ethylene glycol monomethyl or monoethyl ether, ethylene glycol dimethyl ether (diglyme); ketones such as acetone or butanone; amides such as acetamide, dimethylacetamide or dimethylformamide (DMF); nitriles such as acetonitrile; sulfoxides such as dimethylsulfoxide (DMSO); carbon disulfide; carboxylic acids such as formic acid or acetic acid; nitro compounds such as nitromethane or nitrobenzene; esters such as ethyl acetate, or mixtures of said solvents.

[0019] Particularly preferred are acetonitrile, dichloromethane and / or DMF, and particularly preferred is dichloromethane.

[0020] The amide coupling of compound 5 with 3,5-difluorobenzylamine is preferably carried out by the reaction of 3 It is carried out in the presence of P (propanephosphonic anhydride).

[0021] Other preferred acid-activated compounds are as follows: Carbodiimide: EDCI (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide), DCC (dicyclohexylcarbodiimide); Phosphonium salts: BOP (benzotriazolyloxytris(dimethylamino)-phosphonium hexafluorophosphate), PyBOP (benzotriazol-1-yl-oxytripyrrolidinophosphonium-hexafluorophosphate);

[0022] Immonium salts are described in So-Yeop Han, Young-Ah Kim: “Recent development of peptide coupling reagents in organic synthesis: Tetrahedron” 60, 2004, p. 2447;

[0023] Aminium salts: HATU: O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorophosphate; HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium-hexafluorophosphate);

[0024] Uronium salts: COMU ((1-cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylamino-morpholino-carbenium-hexafluorophosphate); Imidazolium salts: The imidazolium salts are described in So-Yeop Han, Young-Ah Kim: “Recent development of peptide coupling reagents in organic synthesis: Tetrahedron”, 60, 2004, p. 2447; HObt (Hydroxybenzotriazole) And so on.

[0025] The oxidation of compound 12 to compound 13 in step C5 is preferably carried out in an organic solvent such as THF or diethyl ether. The reaction is generally carried out in the presence of a base such as NaHMDS (sodium-hexamethyldisilazane), LiHMDS (lithium-hexamethyldisilazane), KHMDS (potassium-hexamethyldisilazane), LDA (lithium diisopropylamide), BuLi (butyl lithium) or potassium tert.butylate. Particularly preferred is NaHMDS.

[0026] The reaction is preferably carried out using the asymmetric oxidation reagent (+)-(2R,4aS,7S,8aR)-4H-4a,7-methanooxazirino[3,2-i][2,1]benzisothiazole, 8,8-dichlorotetrahydro-9,9-dimethyl-3,3-dioxide [ka] This will be implemented.

[0027] Instead of the dichloro compounds the dibromo or difluoro compounds are preferred. The reaction of compound 13 to compound S-9 in step C6 (cleavage of the phenylsulfonyl group) is most preferably carried out with an alkali or alkaline earth metal hydroxide, carbonate or bicarbonate, or another salt of a weak acid of an alkali or alkaline earth metal, preferably of potassium, sodium, calcium or cesium, may also be advantageous. The reaction is preferably carried out in an inert solvent.

[0028] Depending on the conditions used, the reaction time is between a few minutes and 14 days, the reaction temperature is between about -30° and 140°, usually between -10° and 90°, in particular between about 0° and about 70°.

[0029] Examples of suitable inert solvents are hydrocarbons such as hexane, petroleum ether, benzene, toluene or xylene; chlorinated hydrocarbons such as trichloroethylene, 1,2-dichloroethane, carbon tetrachloride, chloroform or dichloromethane; alcohols such as methanol, ethanol, isopropanol, n-propanol, n-butanol or tert-butanol; ethers such as diethyl ether, diisopropyl ether, tetrahydrofuran (THF) or dioxane; glycol ethers such as ethylene glycol monomethyl or monoethyl ether, ethylene glycol dimethyl ether (diglyme);

[0030] ketones such as acetone or butanone; amides such as acetamide, dimethylacetamide or dimethylformamide (DMF); nitriles such as acetonitrile; sulfoxides such as dimethylsulfoxide (DMSO); carbon disulfide; carboxylic acids such as formic acid or acetic acid; nitro compounds such as nitromethane or nitrobenzene; esters such as ethyl acetate, or mixtures of said solvents. Particularly preferred is ethanol and / or THF.

[0031] The reaction of compound 13 to compound S-9 in step C6 (cleavage of the phenylsulfonyl group) is most preferably carried out with NaOH in a mixture of ethanol / THF. More preferably, cleavage of the phenylsulfonyl group from the indole ring is as follows: with tetrabutylammonium fluoride in THF; with magnesium or lithium tert.butoxide in THF; with sodium tert.butylate in dioxane; 1-(N,N-dimethylamino)pyrene in acetonitrile, with triethylamine; with titanium(IV) isopropylate, chloro-trimethyl-silane, magnesium in THF; It will be implemented.

[0032] example Step-1:3 [5-Nitro-1-(phenylsulfonyl)-1H-indole]

[0033] Reaction Scheme: [ka]

[0034] Testing Procedure: 5-Nitroindole 1 (500 g, 3.08 mol) was dissolved in THF (5 L) and the mixture was cooled to 0°C. o The mixture was cooled to 15° C. and stirred for 20 minutes. Sodium hydride (140 g, 3.5 mol) was added in portions and the mixture was stirred for an additional 30 minutes. o The mixture was stirred at rt. Benzenesulnyl chloride 2 (475 mL, 3.7 mol) was introduced through an addition funnel under stirring for 30 min. After completion of addition, the mixture was stirred for 4 h. After completion of the reaction, the reaction mass was cooled to 0° C. and quenched with ice (3 L). Ethyl acetate (5 L) and water (2.5 L) were added. After phase separation, the aqueous layer was re-extracted with ethyl acetate (5 L). The combined organic layers were dried over sodium sulfate and concentrated under reduced pressure at 55° C. Ethyl acetate / pet. ether (8%, 5 L) was added to the crude mass and the mixture was stirred for 20 min at room temperature. The product was filtered and washed with ethyl acetate and pet. ether mixture (5%, 2 L). The product was dried under vacuum to give 3 as a yellow solid. Yield: 890g (95%).

[0035] 1 HNMR (400MHz, DMSO-d 6 )δ8.63-8.55(m,1H),8.26-8.14(m,2H),8.13-8.02(m,3H),7.79-7.70(m,1H),7.69-7.59(m,2H),7.10(d,J=3.7Hz,1H);Molecular formula: C 14 H 10 N 2 O4 S; HPLC purity: 99.92%; Expected LCMS mass: 302.0; Measured value: 161.2 (M-141).

[0036] Step-2:4 1-(Phenylsulfonyl)-1H-indol-5-amine Reaction Scheme: [ka]

[0037] Testing Procedure: Step-1 product 3 (500 g, 1.65 mol) was dissolved in ethanol (7 L). Iron powder (500 g, 8.95 mol) was added and the mixture was stirred for 50 o C. After 15 min, NH 4 An aqueous solution (3.1 L) of Cl (1 kg, 18.69 mol) was added to the reaction mixture through an addition funnel over a period of 1 h. The reaction mixture was cooled to 80 o C for 2 hours. After completion of the reaction, the reaction mass was cooled to 40°C, filtered through celite and concentrated under reduced pressure at 50°C. Ethyl acetate and water (5L each) were added and the layers were separated. The aqueous layer was re-extracted with ethyl acetate (5L). The combined organic layers were dried over sodium sulfate and concentrated under reduced pressure at 50°C. The residue was suspended in ethyl acetate / pet. ether (5%, 5L) and then cooled to room temperature. The product was filtered and washed with ethyl acetate / pet. ether (5%, 5L). The product was dried under vacuum to give 4 as a brown solid. Yield: 400g (89%).

[0038] 1 HNMR (300MHz, DMSO-d 6 )δ7.86(d,J=7.5Hz,2H),7.70-7.42(m,5H),6.67-6.48(m,3H),4.97(s,2H);Molecular formula:C 14 H 12 N 2 O 2S; HPLC purity: 97.25%; Expected LCMS mass: 272.1; Measured value: 273.0 (M+1).

[0039] Step-3:5 2-Oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidine-3-carboxylic acid Reaction Scheme: [ka]

[0040] Testing Procedure: Step-2 product 4 (1.6 kg, 5.87 mol) and cyclopropyl Meldrum's acid (1.2 kg, 7.05 mol) were charged into the reactor followed by acetonitrile (5.5 L) and DMF (1.9 L). The mixture was heated to 70° C. for 16 hours under nitrogen atmosphere. After completion of the reaction, the reaction mass was concentrated under reduced pressure at 50-55° C. The residue was cooled and treated with water and ethyl acetate (10 L each). After phase separation, the organic layer was washed with brine (5 L), dried over sodium sulfate and concentrated under reduced pressure at 40-45° C. The crude solid obtained was washed with ethyl acetate / pet. ether (5%, 2 L) to give 5 as a brown solid. Yield: 1.8 kg (80%).

[0041] 1 HNMR (300MHz, DMSO-d 6 )δ12.80(br.s.,1H),8.02-7.85(m,3H),7.85-7.74(m,2H),7.71-7.47(m,4H),6.84 (d,J=3.6Hz,1H),3.94-3.76(m,2H),3.57(t,J=8.5Hz,1H),2.37-2.20(m,2H);Molecular formula:C 19 H 16 N 2 O 5 S; HPLC purity: 91.51%; Expected LCMS mass: 384.08; Measured value: 385.0 (M+1).

[0042] 5 is the starting point for both racemic and asymmetric synthetic procedures.

[0043] Step-4:6 3-Hydroxy-2-oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidine-3-carboxylic acid Reaction Scheme: [ka]

[0044] Testing Procedure: The product 5 from step-3 (1.0 kg, 2.60 mol) was treated with DMF (8.5 L) and magnesium monoperoxyphthalate hexahydrate 80% (1.9 kg, 3.84 mol). The mixture was heated to 60° C. for 2 h under nitrogen atmosphere. After completion of the reaction, the reaction mass was concentrated under reduced pressure at 50-55° C. The residue was taken in water (5 L) and ethyl acetate (3 L) and stirred at room temperature for 12 h. The product was filtered and washed with water and ethyl acetate (3 L each). The product was 65%. o The mixture was dried under vacuum at 4° C. to give 6 as an off-white solid. Yield: 700g (67%).

[0045] Note: Step 4 product moisture content should be less than 0.5%.

[0046] 1 HNMR (400MHz, DMSO-d 6 )δ7.97-7.94(m,3H),7.87(s,1H),7.81-7.80(d,J=3.4Hz,1H),7.73-7.66(m,2H),7.60-7.56(m,2H),7.16(brs,1H),6.87(d ,J=3.4Hz,1H),3.92(q,J=8.4Hz,1H),3.75(t,J=8.7Hz,1H),3.45-3.42(m,1H),2.43-2.38(m,1H),2.03-1.96(m,1H);Molecular formula: C 19 H 16 N2 O 6 S; HPLC purity: 96.12%; Expected LCMS mass: 400.07; Measured value: 401.0 (M+1).

[0047] Step-5:7 3-Acetoxy-2-oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidine-3)pyrrolidine-3-carboxylic acid Reaction Scheme: [ka]

[0048] Testing Procedure: Step-4 product 6 (1.0 kg, 2.5 mol) and DMF (8 L) were charged into a reactor and stirred at room temperature for 10 min. Acetic anhydride (355 mL, 3.75 mol) was slowly added to the mass and the mixture was stirred for 12 h. After completion of the reaction, the reaction mass was concentrated under reduced pressure at 50-55° C. The residue was 0.05%. o The mixture was cooled to 5° C., suspended in water (5 L) and stirred overnight at room temperature. The precipitate was filtered, washed with water (3 L) and then suspended in acetone (3 L) for 1 h. Filtration gave the product 7 as a white solid, which was extracted under vacuum at 65° C. o It was dried at C. Yield: 940g (85%). Note: The moisture content of the Step 5 product should be less than 0.5%.

[0049] 1 HNMR (400MHz, DMSO-d 6 )δ7.98-7.89(m,3H),7.86-7.77(m,2H),7.73-7.62(m,2H),7.60-7.51(m,2H),6.85(d,J=3.8Hz,1H),3.98( Molecular formula: C 21 H18 N 2 O 7 S; HPLC purity: 97.83%; Expected LCMS mass: 442.08; Measured value: 443.0 (M+1). Note: The reaction mixture was 55 o C and evaporation should be complete within 2 hours. Higher temperatures and extended heating will lead to decarboxylation of the product.

[0050] Step-6:8 3-((3,5-difluorobenzyl)carbamoyl)-2-oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidin-3-yl acetate. Reaction Scheme: [ka]

[0051] Testing Procedure: Step-5 Product 7 (1.0 kg, 2.26 mol) was stirred at room temperature for 10 min in CH 2 Cl 2 (10 L) and then 0 o The mixture was cooled to 5°C. Triethylamine (690 mL, 4.95 mol), 3,5-difluorobenzylamine (405 g, 2.83 mol) and 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide (2.15 L, 3.38 mol) were added and the reaction mixture was stirred at room temperature for 2 hours. After completion of the reaction, the reaction mass was diluted with water (5 L) and stirred for 10 minutes. The aqueous layer was removed from the top. This water washing was repeated three times. The organic layer was filtered and the precipitate was separated by CH4. 2 Cl 2 (1 L) and acetone (0.5 L) to give 8 as an off-white solid. Yield: 1.07 kg (83%).

[0052] 1 HNMR (400MHz, DMSO-d 6)δ8.99(t,J=6.2Hz,1H),7.97(d,J=8.1Hz,3H),7.83(dd,J=2.8,5.2Hz,2H), 7.72-7.63(m,2H),7.62-7.53(m,2H),7.06(t,J=9.4Hz,1H),6.93(d,J=7.0H z,2H),6.87(d,J=3.5Hz,1H),4.33(dq,J=6.0,16.1Hz,2H),3.99-3.83(m,2H ),2.88(ddd,J=2.6,7.9,13.2Hz,1H),2.43-2.28(m,1H),2.18(s,3H);Molecular formula:C 28 H 23 F 2 N 3 O 6 S; HPLC purity: 99.88%; Expected LCMS mass: 567.13; Measured value: 568.0 (M+1).

[0053] Step-7:9 N-(3,5-difluorobenzyl)-3-hydroxy-1-(1H-indol-5-yl)-2-oxopyrrolidine-3-carboxamide Reaction Scheme: [ka]

[0054] Testing Procedure: Step-6 Product 8 (1.2 kg, 2.11 mol) was dissolved in ethanol (5 L) and THF (10 L) and stirred at room temperature for 10 min. Sodium hydroxide (422 g, 10.55 mol) was added and stirred for 50 min for 2 h. o After completion of the reaction, the reaction mass was concentrated under reduced pressure at 45°C. The residue was dissolved in ethyl acetate (10 L) and water (5 L). After phase separation, the organic layer was washed with water (2 x 5 L) and brine (5 L). The organic layer was dried over sodium sulfate, filtered and concentrated under reduced pressure at 45-50°C. CH 2 Cl 2 (1 L) was added to the remainder and the precipitate was filtered and added to CH 2 Cl 2(1.0 L) to give 9 as an off-white solid. Yield: 700g (86%).

[0055] 1 HNMR (400MHz, DMSO-d 6 )δ11.12(br.s.,1H),8.69(t,J=6.4Hz,1H),7.70(s,1H),7.46-7.32(m,3H),7.12-6.94(m,3H),6.69(s,1H),6.47-6.38(m,1H),4. 41(dd,J=6.9,16.0Hz,1H),4.25(dd,J=5.9,15.8Hz,1H),3.94-3.81(m,2H),2.66-2.54(m,1H),2.13(td,J=7.6,13.0Hz,1H);Molecular formula: C 20 H 17 F 2 N 3 O 3 ; HPLC purity: 98.11%; Expected LCMS mass: 385.12; Measured value: 386.0 (M+1).

[0056] SFC separation: The 9 isomers (5.20 Kg) were isolated via SFC purification. SFC method: Column: Lux Amylose-2 (250 x 30) mm, 5 microns Mobile phase: CO 2 :MeOH(60:40) Flow rate: 200g / min Runtime: 10 minutes (cycle time) Filling per injection: 700mg

[0057] [Table 1]

[0058] Fraction 1 (S-9): 1 HNMR (400MHz, DMSO-d 6)δ11.12(br.s.,1H),8.69(t,J=6.4Hz,1H),7.70(s,1H),7.46-7.32(m,3H),7.12-6.94(m,3H),6.69(s,1H),6.47-6.38(m,1H),4. 41(dd,J=6.9,16.0Hz,1H),4.25(dd,J=5.9,15.8Hz,1H),3.94-3.81(m,2H),2.66-2.54(m,1H),2.13(td,J=7.6,13.0Hz,1H);Molecular formula: C 20 H 17 F 2 N 3 O 3 ; HPLC purity: 99.46%; Chiral HPLC purity: 100%; Expected LCMS mass: 385.12; Found: 386.0 (M+1); SOR: +14.69.

[0059] Fraction 2 (R-9): 1 HNMR (400MHz, DMSO-d 6 )δ11.12(br.s.,1H),8.69(t,J=6.3Hz,1H),7.73-7.68(m,1H),7.45-7.31(m,3H),7.11-6.94(m,3H),6.69(s,1H),6.46-6.38(m,1H), Molecular formula: C 20 H 17 F 2 N 3 O 3 ; HPLC purity: 97.20%; Chiral HPLC purity: 98.17%; Expected LCMS mass: 385.12; Found: 386.2 (M+1); SOR: -13.49.

[0060] Mixture of fractions (1&2): HPLC purity: 98.90%; Chiral HPLC purity: 32.99% (fraction 1) & 67.01 (fraction 2). Optimization of the yield can be achieved by inversion of the chiral center. The procedure invented is outlined below.

[0061] Step 8:10 (R)-3-((3,5-difluorobenzyl)carbamoyl)-1-(1H-indol-5-yl)-2-oxopyrrolidin-3-yl methanesulfonate Reaction Scheme: [ka]

[0062] Testing Procedure: Dry ice-cooled R-9 (200 g, 0.52 mol) in CH 2 Cl 2 To the solution (2 L), Et 3 N (252 ml, 1.81 mol) was added followed by dropwise addition of mesyl chloride (80.4 ml, 1.03 mol). The reaction mixture was stirred at the same temperature for an additional 2 h. Upon completion, the reaction mixture was diluted with water (1.5 L), 5% citric acid (1 L) and NaHCO 3 The combined organic extracts were washed with brine (1 L) and then with a saturated aqueous solution of Na 2 SO 4 The mixture was dried over 500 ml, filtered, and concentrated in vacuo to yield 10 (260 g). The crude product was immediately carried onto the next step without further purification. Molecular formula:C 21 H 19 F 2 N 3 O 5 S; HPLC purity: 81.76%; Expected LCMS mass: 463.10; Measured value: 464.0 (M+1).

[0063] Step 9:11 (S)-3-((3,5-difluorobenzyl)carbamoyl)-1-(1H-indol-5-yl)-2-oxopyrrolidin-3-yl acetate Reaction Scheme: [ka]

[0064] Testing Procedure: Cesium acetate (214 g, 1.12 mol) in dry DMF (1.2 L) was added to 100 o At C, a solution of 10 (260 g, 0.560 mol) in DMF (1.0 L) was added dropwise through an addition funnel over 20 min. Heating was continued for an additional 1.5 h. After completion, the reaction mass was concentrated under vacuum. The crude mass was dissolved in ethyl acetate (2 L) and washed with water (2 x 2 L). The combined organic extracts were washed with brine (1 L) and sodium hydroxide. 2 SO 4 The mixture was dried over 500 ml, filtered, and concentrated in vacuo to yield 11 (250 g). The crude product was immediately carried onto the next step without further purification. Molecular formula:C 22 H 19 F 2 N 3 O 4 ; HPLC purity: 45.64%; Expected LCMS mass 427.13; Measured value: 428.3 (M+1).

[0065] Step 10: S-9 (S)-N-(3,5-difluorobenzyl)-3-hydroxy-1-(1H-indol-5-yl)-2-oxopyrrolidine-3-carboxamide Reaction Scheme: [ka]

[0066] Testing Procedure: To an ice-cold solution of crude 11 (250 g, 0.52 mol) in methanol (2.5 L) was added NaOH pellets (63 g, 1.56 mol). The reaction mixture was stirred at room temperature for 2 h. After completion, methanol was removed under vacuum to <55 °C. 0 The mixture was concentrated at 37° C. The crude mass was dissolved in ethyl acetate (2 L) and washed with water (3×2 L). The combined organic extracts were washed with brine (1 L) and sodium 2 SO 4The mixture was dried over 1000 ml of ethyl acetate, filtered and concentrated under vacuum. It was passed through a washing column (silica 60-120) and non-polar impurities were removed using 30-40% ethyl acetate / pet. ether. The product was diluted with 3-5% MeOH / CH 2 Cl 2 The isolated product was dissolved in a minimum amount of ethyl acetate and stored in the cold for 16 hours. The solid that formed was filtered through a Buchner funnel and washed with ethyl acetate (3×100 mL) to give S-9 (56 g, 28% over three steps) as an off-white solid.

[0067] The dried solid was ground in a pin mill (rpm 6000, 30 min) to obtain the final API. 1 HNMR (400MHz, DMSO-d 6 )δ11.12(br.s.,1H),8.69(t, J=6.4Hz,1H),7.70(s,1H),7.46-7.32(m,3H),7.12-6.94(m,3H),6.69(s,1H),6.47-6.38(m,1H),4.41(dd,J=6.9,1 Molecular formula: C 20 H 17 F 2 N 3 O 3 ; HPLC purity: 98.72%; Chiral HPLC purity: 98.68%; (ee: 97.36%); Expected LCMS mass: 385.12; Found: 386.2 (M+1).

[0068] Particle size:<18μm. SOR: +13.62. MP: 195.3-198.9℃ MC: 0.21% Residual Solvents: Methanol -----17ppm Ethanol -----ND ACN------------ND CH 2 Cl 2 ------------ND Ethyl acetate -----75ppm THF -------------206ppm n-Heptane ------47 ppm

[0069] Step-4C:12 1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-2-oxopyrrolidine-3-carboxamide [ka]

[0070] Testing Procedure: Ice-cold 5 (750 g, 1.95 mol) in CH 2 Cl 2 To the solution (7 L), Et 3 N (600 mL, 4.29 mol) was added, followed by 3,5-difluorobenzylamine (363 g, 2.53 mol). 3 P(propanephosphonic anhydride) (1.86 L (50% ethyl acrylate [ethyl acetate] solution), 3.0 mol) was slowly added dropwise into the reaction mixture and the reaction mixture was stirred at room temperature for 2 hours. After completion of the reaction, the reaction mass was quenched with water (3 L) and stirred for 10 minutes. The organic layer was separated and diluted with 10% NaHCO 3 The organic phase was finally washed with brine (3 L), dried over anhydrous sodium sulfate, and concentrated to give the crude product as a light brown solid. It was slurried with a minimum amount of ethyl acetate (1.5 L) and filtered. The cake was washed with ice-cold ethyl acetate (1 L x 2) to give the pure product as an off-white solid, HPLC >99%.

[0071] Amount obtained: 720 g; Yield: 72%; 1H-NMR (400MHz, DMSO-d 6 ):8.82(t,J=5.60Hz,1H),7.99-7.94(m,3H),7.83(d,J=2.80Hz,2H),7.71-7.67(m,2H),7.61-7.57(m,2H),7.12-7.05(m,3H),6.87(d,J=3 .60Hz,1H),4.49(dd,J=6.80,16.20Hz,1H),4.27(dd,J=5.20,16.00Hz,1H),3.90-3.85(m,2H),3.63(t,J=8.80Hz,1H),2.40-2.27(m,2H).

[0072] Step C5:13 (3S)-1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-3-hydroxy-2-oxopyrrolidine-3-carboxamide [ka]

[0073] Testing Procedure: A suspension of 12 (500 g, 0.98 mol) in dry THF (7.5 L) was o The mixture was cooled to -55°C (internal temperature). NaHMDS solution (1078 mL, 1M in THF) was added dropwise over a period of 1.5 hours while maintaining the same temperature range. After the addition was complete, the temperature of the reaction mixture was -55°C. o C for another hour and then internal -68 o The mixture was cooled again to 30° C. To the yellow reaction mixture was added dropwise a solution of ((+)-(2R,4aS,7S,8aR)-4H-4a,7-methanooxazirino[3,2-i][2,1]benzisothiazole, 8,8-dichlorotetrahydro-9,9-dimethyl-3,3-dioxide (365 g, 1.22 mol) in THF (1.1 L) over a period of 1.3 h at the same temperature. The reaction mass was further stirred for 1.5-25 h. o After the conversion was complete, the system was cooled to -15 °C with ice / water (2 L). oC. Ethyl acetate (5 L) was added to the reaction mixture, the organic layer was separated and washed with water (3 L). The aqueous layer was saturated with NaCl and re-extracted with ethyl acetate (1 L). The combined organic layers were finally washed with brine and Na 2 SO 4 The crude product was purified by column chromatography (SiO 2 The product was eluted in 50-60% ethyl acetate and obtained as an off-white solid.

[0074] Amount obtained: 375 g; yield: 73%. 1 HNMR (500MHz, DMSO-d 6 )ppm=8.67(t,J=6.4,1H),7.98-7.92(m,3H),7.86(d,J=2.2,1H),7.82(d,J=3.7,1H),7.75-7.65(m,2H),7.61-7 .55(m,2H),7.05(tt,J=9.3,2.4,1H),7.01-6.93(m,2H),6.89-6.84(m,1H),6.72(s,1H),4.39(dd,J=15.8,6.8, 1H), 4.25 (dd, J=15.8, 6.0, 1H), 3.90-3.83 (m, 2H), 2.65-2.54 (m, 1H), 2.17-2.09 (m, 1H). LCMS System A: H2O + 0.05% HCOOH | System B: MeCN + 0.04% HCOOH; T: 30 °C | Flow: 2.4 ml / min | Column: Chromolith RP-18e100-3 | MS: 85-800 amu. Gradient: 4%-->100% (B) 0-->2.8 min | 100% (B) 2.8-3.3 min. Retention time: 2.376 min (M+H + ):526.1. Note: The average chiral purity achieved during this step was 85% and the maximum was 87%. It is important to note that any washing of the crude product results in a significant reduction in chiral purity.

[0075] The structure of Davis oxaziridine: [ka]

[0076] Step C6: S-9 (S)-3-Hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide [ka]

[0077] Testing Procedure: Sodium hydroxide pellets (140 g, 3.56 mol) were stirred at room temperature. 13 (375 g, 0.71 mol) was added to a suspension in a mixture of ethanol / THF (3 L / 1 L). o C for 2 h. After completion of conversion, the reaction mixture was concentrated to give a crude mass. Water (4 L) was added and stirred at room temperature for 1 h. The formed solid was filtered through a Buchner funnel and neutralized with 1.5 N HCl, followed by washing with water (1 L x 3). The residue was finally washed with ether (2 L) to give the crude product. The chiral purity of the compound was confirmed at this stage and found to be 95.5%.

[0078] To increase the chiral purity, the solid was dissolved in a minimum amount of THF / ethyl acetate (9:1) and diluted with 60 o The mixture was heated to reflux at 37 °C for 30 min. The solution was filtered through a Büchner funnel and the clear filtrate was cooled on ice for 2-3 h and the solids that had formed were filtered off. The filtrate was again cooled on ice for 2 h and the solids were filtered off separately. The chiral purity of each solid was confirmed and all fractions were combined to ee > 98.7% and purified by column chromatography (SiO 2 The product was finally purified by HPLC using a 230-400 mesh column. The pure product was eluted with 2% methanol and concentrated under reduced pressure to give the desired S-9 as an off-white solid.o C for 12 hours. The amount obtained was 140 g; yield was 51%.

[0079] Note 01 If the chiral purity of crude S-9 was >97%, the mass was treated with a minimum volume of ethyl acetate / THF (3V, 9:1), stirred for 30 min at room temperature and filtered to yield the desired chiral purity >98.7%. Note 02 The main aqueous layer was taken up and acidified with 2N HCl, and the solid that formed was filtered off. The cake was neutralized by washing with water and finally with cold ethyl acetate, yielding the remaining compound with 60% chiral purity.

Claims

1. 1. A process for producing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide ("S-9"), comprising the steps of: a) 2-oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidine-3-carboxylic acid ("5") is reacted with 3,5-difluorobenzylamine to provide 1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-2-oxopyrrolidine-3-carboxamide ("12"); b) "12" is then enantioselectively oxidized to afford (3S)-1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-3-hydroxy-2-oxopyrrolidine-3-carboxamide ("13"); c) and then cleaving the phenylsulfonyl group from "13" to give (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide ("S-9"); The process,

2. 2. The process of claim 1, wherein a) is carried out in the presence of a base selected from triethylamine, DBU, or di-isopropylethylamine.

3. 3. The process according to claim 1 or 2, wherein a) is carried out in dichloromethane.

4. 4. The process of claim 1, 2 or 3, wherein a) is carried out in the presence of propanephosphonic anhydride.

5. 2. The process of claim 1, wherein b) is carried out in the presence of (+)-(2R,4aS,7S,8aR)-4H-4a,7-methanooxazirino[3,2-i][2,1]benzisothiazole, 8,8-dichlorotetrahydro-9,9-dimethyl-3,3-dioxide.

6. 6. The process according to claim 1 or 5, wherein b) is carried out in the presence of THF or diethyl ether.

7. 7. The process of claim 1, 5 or 6, wherein b) is carried out in the presence of NaHMDS.

8. 2. The process of claim 1, wherein c) is carried out in the presence of NaOH.

9. The intermediate compound 1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-2-oxopyrrolidine-3-carboxamide (12).

Citation Information

Patent Citations

  • Pyrrolidinone as a MetAP2 inhibitor

    JP2013544781A

  • Cyclic amides as METAP-2 inhibitors

    JP2015512426A

  • Method for producing (+)-tricyclohydroxylactone

    JP2016513091A

  • Pyrrolidinone derivatives as metap-2 inhibitors

    JP2017523995A

  • 5-hydroxy-4-(trifluoromethyl)pyrazolopyridine derivative

    WO2015087994A1